Supplements for the Treatment of Mild COVID-19—Challenging Health Beliefs With Science From A to Z
Authors:
- 1 February 2021
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (2) , e210431
Abstract
Coronavirus disease 2019 (COVID-19) is a major cause of death and disability worldwide, totaling 89.4 million cases and 1.9 million deaths globally as of JanuarKeywords
This publication has 3 references indexed in Scilit:
- Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 InfectionJAMA Network Open, 2021
- Enhancing immunity in viral infections, with special emphasis on COVID-19: A reviewDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular OutcomesAnnals of Internal Medicine, 2019